Understanding the Underlying Mechanisms of Gastric and Esophageal Cancer
Understanding how gastric and esophageal cancers are triggered and their genetic makeup is vital to developing and testing new therapies, according to... Read More
Immunotherapy Continues to Show Promise in Treating Gastric Cancers
In the phase 1b JAVELIN trial, pretreated patients with gastric/gastroesophageal junction cancers (GC/GEJ) responded well to avelumab, a PD-L1 antibody.
Survey Seeks Gastric Patients with ROS1 Gene Fusions
A respected cancer foundation is collaborating with Stanford University to focus on a subset of cancer patients whose tumors have ROS1 gene... Read More
Landmark cancer study reveals huge regional gaps in incidence rates; lifestyle habits may be to blame
A landmark study of cancer diagnoses in Japan has revealed huge regional gaps in incidence rates in what one official said reflected... Read More
FDA Grants Napabucasin Orphan Drug Status for Gastric Cancer
Boston Biomedical announced that the Food and Drug Administration (FDA) has granted Orphan Drug designation for its investigational compound, napabucasin, for the... Read More
Billionaire-backed Ganymed grabs ASCO spotlight with gastric cancer drug
Investigators on the drug say that Ganymed’s IMAB362 “can significantly extend median survival when added to standard chemotherapy–13.2 months vs. 8.4 months–for... Read More
Pioneering Data Sharing Network Created to Accelerate Cancer Precision Medicine Development
Intermountain Healthcare, Stanford Cancer Institute, Providence Health & Services, and Syapse joined together today to announce a new consortium to advance cancer... Read More
Study identifies potential new treatment for subset of gastric cancer patients
Testing cancers for ‘addiction’ to a gene that boosts cell growth can pick out patients who may respond to a targeted drug... Read More
Singapore chemo trial gives hope to gastric cancer patients
A form of chemotherapy trialled in Singapore on patients with advanced gastric cancer has shown promise in prolonging their lives.
Targeting Molecular Pathways in Gastric Cancer: Current Status and Future View
Progress has been made in understanding the biology behind esophagogastric cancer, and several targeted strategies have been developed or are under development.